D-erythro-Imidazoleglycerol phosphate monohydrate
CAS: 210241-69-3
Ref. 3D-FE22793
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 500µg | To inquire |
Product Information
- IGP
D-erythro-Imidazoleglycerol phosphate monohydrate (D-ERGP) is a drug that has been used for the treatment of chronic diseases. This drug is an analog of erythromycin, which has been shown to be active against some strains of bacteria resistant to tetracycline. D-ERGP is not a bacteriostatic agent and does not have significant interactions with other drugs. It has been shown to reduce blood pressure in animal models and human patients with diabetes mellitus, although it does not have significant effects on cholesterol levels or triglycerides. D-ERGP has also been shown to inhibit the growth of parasitoid wasps in vitro, but this effect is not observed in vivo. The catalytic mechanism of D-ERGP is unknown.
Chemical properties
Technical inquiry about: 3D-FE22793 D-erythro-Imidazoleglycerol phosphate monohydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
